Paola Nistico

Via Elio Chianesi, 53-00144 Rome
Rome, 00144, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 65 publications

17β-Estradiol Modulates Cancer Cell-Fibroblast Communication via Autophagy-Mediated Extracellular Vesicle Secretion and Promotes Poor Prognosis in Non-Small Cell Lung Cancer.

17β-Estradiol Modulates Cancer Cell-Fibroblast Communication via Autophagy-Mediated Extracellular Vesicle Secretion and Promotes Poor Prognosis in Non-Small Cell Lung Cancer.

Journal: International journal of molecular sciences
Published: June 25, 2026

Phenotypic characterization and function of tumor infiltrating and peripheral B cells in cancer patients.

Phenotypic characterization and function of tumor infiltrating and peripheral B cells in cancer patients.

Journal: Methods in cell biology
Published: February 13, 2026

Optimized phospho-flow cytometry for quantitative analysis of early TCR-proximal signaling: Implications for T cell function in onco-immunology.

Optimized phospho-flow cytometry for quantitative analysis of early TCR-proximal signaling: Implications for T cell function in onco-immunology.

Journal: Methods in cell biology
Published: February 13, 2026

Methodological advances to analyze cancer-associated fibroblast-derived ECM effects on macrophage polarization.

Methodological advances to analyze cancer-associated fibroblast-derived ECM effects on macrophage polarization.

Journal: Methods in cell biology
Published: February 13, 2026

Challenges and advances in drug resistance and tolerance in cancer.

Challenges and advances in drug resistance and tolerance in cancer.

Journal: Journal of experimental & clinical cancer research : CR
Published: January 21, 2026

Reciprocal regulation of hMENA and TGF-β signaling in cancer-associated fibroblasts promotes EMT, immunosuppression, poor prognosis, and ICT resistance in NSCLC.

Reciprocal regulation of hMENA and TGF-β signaling in cancer-associated fibroblasts promotes EMT, immunosuppression, poor prognosis, and ICT resistance in NSCLC.

Journal: Journal for immunotherapy of cancer
Published: January 11, 2026

Hyperprogression Upon Cemiplimab Alone or With Short Course Chemotherapy in PD-L1 ≥ 50% Non-small Cell Lung Cancer: A Biomarker Guided Multicenter International Phase 2 Trial-HYPERBOLIC Study.

Hyperprogression Upon Cemiplimab Alone or With Short Course Chemotherapy in PD-L1 ≥ 50% Non-small Cell Lung Cancer: A Biomarker Guided Multicenter International Phase 2 Trial-HYPERBOLIC Study.

Journal: Clinical lung cancer
Published: January 11, 2026

Tertiary lymphoid structures in the era of cancer therapy.

Tertiary lymphoid structures in the era of cancer therapy.

Journal: Journal of experimental & clinical cancer research : CR
Published: December 01, 2025

Spatial transcriptomics highlights B cells as key contributors to a complete and durable response to chemo-immunotherapy in a patient with resectable NSCLC.

Spatial transcriptomics highlights B cells as key contributors to a complete and durable response to chemo-immunotherapy in a patient with resectable NSCLC.

Journal: Journal for immunotherapy of cancer
Published: May 01, 2025

Highlighting recent achievements to advance more effective cancer immunotherapy.

Highlighting recent achievements to advance more effective cancer immunotherapy.

Journal: Journal of experimental & clinical cancer research : CR
Published: December 21, 2024

ADA/CD26 axis increases intra-tumor PD-1+CD28+CD8+ T-cell fitness and affects NSCLC prognosis and response to ICB.

ADA/CD26 axis increases intra-tumor PD-1+CD28+CD8+ T-cell fitness and affects NSCLC prognosis and response to ICB.

Journal: Oncoimmunology
Published: June 25, 2024

Trajectory of PD-L1 expression in a patient underwent neoadjuvant chemo-immunotherapy for resectable NSCLC.

Trajectory of PD-L1 expression in a patient underwent neoadjuvant chemo-immunotherapy for resectable NSCLC.

Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 08, 2024
Showing 1-12 of 65

Last Updated: 09/26/2026